Reaction Details Report a problem with these data
Target
Proteinase-activated receptor 4
Ligand
BDBM50600785
Substrate
n/a
Meas. Tech.
ChEMBL_2234808 (CHEMBL5148580)
IC50
0.800000±n/a nM
Citation
Priestley, ES; Banville, J; Deon, D; Dubé, L; Gagnon, M; Guy, J; Lapointe, P; Lavallée, JF; Martel, A; Plamondon, S; Rémillard, R; Ruediger, E; Tremblay, F; Posy, SL; Guarino, VR; Richter, JM; Li, J; Gupta, A; Vetrichelvan, M; Balapragalathan, TJ; Mathur, A; Hua, J; Callejo, M; Guay, J; Sum, CS; Cvijic, ME; Watson, C; Wong, P; Yang, J; Bouvier, M; Gordon, DA; Wexler, RR; Marinier, A Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4. J Med Chem 65:8843-8854 (2022) [PubMed]
More Info.:
Target
Name:
Proteinase-activated receptor 4
Synonyms:
Coagulation factor II receptor-like 3 | F2RL3 | PAR-4 | PAR4 | PAR4_HUMAN | Proteinase-activated receptor 4 | Proteinase-activated receptor 4 (PAR4) | Thrombin receptor-like 3
Type:
Protein
Mol. Mass.:
41145.16
Organism:
Human
Description:
Q96RI0
Residue:
385
Sequence:
MWGRLLLWPLVLGFSLSGGTQTPSVYDESGSTGGGDDSTPSILPAPRGYPGQVCANDSDTLELPDSSRALLLGWVPTRLVPALYGLVLVVGLPANGLALWVLATQAPRLPSTMLLMNLAAADLLLALALPPRIAYHLRGQRWPFGEAACRLATAALYGHMYGSVLLLAAVSLDRYLALVHPLRARALRGRRLALGLCMAAWLMAAALALPLTLQRQTFRLARSDRVLCHDALPLDAQASHWQPAFTCLALLGCFLPLLAMLLCYGATLHTLAASGRRYGHALRLTAVVLASAVAFFVPSNLLLLLHYSDPSPSAWGNLYGAYVPSLALSTLNSCVDPFIYYYVSAEFRDKVRAGLFQRSPGDTVASKASAEGGSRGMGTHSSLLQ